EP 1244467 A4 20050105 - PHOSPHOGLYCERATE KINASE IN THE TREATMENT OF DISEASE
Title (en)
PHOSPHOGLYCERATE KINASE IN THE TREATMENT OF DISEASE
Title (de)
PHOSPHOLGLYERAT-KINASE ZUR BEHANDLUNG VON KRANKHEITEN
Title (fr)
PHOSPHOGLYCERATE KINASE DANS LE TRAITEMENT DE MALADIES
Publication
Application
Priority
- AU 0001542 W 20001213
- AU PQ475499 A 19991217
Abstract (en)
[origin: WO0143767A1] The present invention provides a pharmaceutical composition for the inhibition of angiogenesis associated with disease in a vertebrate, said composition comprising phosphoglycerate kinase, or a fragment(s) or analogue thereof, together with a pharmaceutically acceptable carrier, adjuvant and/or diluent. The present invention also relates to the treatment of disease, especially cancer, in a vertebrate via the administration of a therapeutically effective amount of phosphoglycerate kinase (PGK), or fragment(s) or analogue thereof.
IPC 1-7
A61K 38/44; A61K 39/395; A61K 48/00; A61P 35/00; G01N 33/574; G01N 33/68; A61K 38/45; A61K 38/49; A61K 51/00
IPC 8 full level
A61K 38/45 (2006.01); A61K 38/49 (2006.01); C07K 16/40 (2006.01); G01N 33/574 (2006.01)
CPC (source: EP)
A61K 38/45 (2013.01); A61K 38/49 (2013.01); A61P 35/00 (2017.12); C07K 16/40 (2013.01); G01N 33/57488 (2013.01); A61K 2039/505 (2013.01)
Citation (search report)
- [PX] LAY A ET AL: "Phosphoglycerate kinase is secreted by tumor cells and participates in tumor angiogenesis as a disulfide reductase", JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, vol. 32, no. 3, July 2000 (2000-07-01), & XITH INTERNATIONAL VASCULAR BIOLOGY MEETING; GENEVA, SWITZERLAND; SEPTEMBER 05-09, 2000, pages 336, XP008038496, ISSN: 1122-9497
- See references of WO 0143767A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0143767 A1 20010621; AU PQ475499 A0 20000120; EP 1244467 A1 20021002; EP 1244467 A4 20050105
DOCDB simple family (application)
AU 0001542 W 20001213; AU PQ475499 A 19991217; EP 00984641 A 20001213